A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis.
D000082:Acetaminophen / Q000627:therapeutic use; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000475:Alkenes / Q000627:therapeutic use*; D000700:Analgesics / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003875:Drug Eruptions / Q000209:etiology; D004790:Enzyme Induction; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011485:Protein Binding; D011720:Pyrazoles / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D000475:Alkenes; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D000082:Acetaminophen; D007213:Indomethacin